News

Moderna's next COVID-19 vaccine has received Food and Drug Administration approval, albeit with restrictions not placed on the company's current shot. The new vaccine, called mNEXSPIKE, can be ...
mNEXSPIKE becomes Moderna’s third FDA-approved product. CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration ...